Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Significant Decrease in Short Interest

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a large drop in short interest during the month of September. As of September 15th, there was short interest totaling 15,082,316 shares, a drop of 41.2% from the August 31st total of 25,660,865 shares. Based on an average daily volume of 530 shares, the short-interest ratio is currently 28,457.2 days. Approximately 0.1% of the shares of the company are short sold.

Sino Biopharmaceutical Stock Performance

SBMFF stock opened at $0.70 on Thursday. Sino Biopharmaceutical has a 1 year low of $0.59 and a 1 year high of $1.07. The stock’s fifty day moving average is $0.68 and its two-hundred day moving average is $0.69.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across areas including oncology, liver disease, respiratory conditions, digestive disorders, cardiovascular disease and orthopedics.

Its business includes generic medicines, innovative therapies, biologic products and traditional Chinese medicine. Key operating subsidiaries and research units include Chia Tai Tianqing Pharmaceutical Group, which has been associated with the development and commercialization of oncology and hepatology treatments, as well as other companies focused on pharmaceutical research, manufacturing and distribution.

Established in 2000, Sino Biopharmaceutical primarily serves the Chinese pharmaceutical market and has pursued international development and commercialization opportunities for selected products.